Literature DB >> 30688689

Prothrombin Complex Concentrate Use in Durable and Short-Term Left Ventricular Assist Device Implantation.

Yaron D Barac1, Adam Nevo1, Oliver Jawitz1, Nazish K Hashmi2, Peter Henkel3, Laura J Blue1, Joseph Kelly4, Chetan B Patel4, Mani A Daneshmand1, Jacob N Schroder1, Carmelo A Milano1, Ian Welsby2.   

Abstract

Entities:  

Year:  2020        PMID： 30688689      PMCID： PMC7291592          DOI： 10.1097/MAT.0000000000000937

Source DB:  PubMed          Journal:  ASAIO J        ISSN： 1058-2916            Impact factor:   3.826


× No keyword cloud information.
  9 in total

Review 1.  Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.

Authors:  James K Kirklin; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young; David C Naftel
Journal:  J Heart Lung Transplant       Date:  2017-07-15       Impact factor: 10.247

2.  Safety of Prothombin Complex Concentrate to Control Excess Bleeding During Continuous Flow LVAD Insertion.

Authors:  Chad D Bradford; Marcia J Stahovich; Walter P Dembitsky; Robert M Adamson; John J Engelbert; Alexandra S Perreiter
Journal:  ASAIO J       Date:  2015 Sep-Oct       Impact factor: 2.872

3.  Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

Authors:  M Makris; M Greaves; W S Phillips; S Kitchen; F R Rosendaal; E F Preston
Journal:  Thromb Haemost       Date:  1997-03       Impact factor: 5.249

4.  Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.

Authors:  Jessica Rimsans; Amy Levesque; Erin Lyons; Katelyn Sylvester; Michael M Givertz; Mandeep R Mehra; Garrick C Stewart; Jean M Connors
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 5.  The biological basis of thrombosis and bleeding in patients with ventricular assist devices.

Authors:  Ranjit John; Sangjin Lee
Journal:  J Cardiovasc Transl Res       Date:  2008-10-17       Impact factor: 4.132

Review 6.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

7.  Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices.

Authors:  Douglas L Jennings; Minu Jacob; Anuvrat Chopra; Carrie W Nemerovski; Jeffrey A Morgan; David E Lanfear
Journal:  ASAIO J       Date:  2014 Jul-Aug       Impact factor: 2.872

8.  Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery.

Authors:  Howard K Song; Frederick A Tibayan; Ed A Kahl; Valerie A Sera; Matthew S Slater; Thomas G Deloughery; Mick M Scanlan
Journal:  J Thorac Cardiovasc Surg       Date:  2013-12-22       Impact factor: 5.209

Review 9.  Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.

Authors:  Cindy A Leissinger; Philip M Blatt; W Keith Hoots; Bruce Ewenstein
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.